IDYA

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Ideaya Biosciences Inc

NASDAQ | IDYA

27.08

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 14, 2025)

$2.35B

Market Cap

-

P/E Ratio

-3.84

EPS

$32.67

52 Week High

$13.45

52 Week Low

HEALTHCARE

Sector

IDYA Chart

Recent Chart
Price Action

IDYA Technicals

Tags:

IDYA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $7M
Total Revenue $7M
Cost Of Revenue $3.8M
Costof Goods And Services Sold $3.8M
Operating Income -$327M
Selling General And Administrative $39M
Research And Development $295M
Operating Expenses $334M
Investment Income Net -
Net Interest Income $52M
Interest Income $52M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$274M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$274M
Comprehensive Income Net Of Tax -
Ebit -$327M
Ebitda -$327M
Net Income -$274M

Revenue & Profitability

Earnings Performance

IDYA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.1B
Total Current Assets $690M
Cash And Cash Equivalents At Carrying Value $84M
Cash And Short Term Investments $84M
Inventory -
Current Net Receivables $3K
Total Non Current Assets $434M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $406M
Short Term Investments $592M
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $65M
Total Current Liabilities $46M
Current Accounts Payable $15M
Deferred Revenue -
Current Debt -
Short Term Debt $596K
Total Non Current Liabilities $19M
Capital Lease Obligations $19M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $19M
Other Current Liabilities $30M
Other Non Current Liabilities -
Total Shareholder Equity $1.1B
Treasury Stock -
Retained Earnings -$623M
Common Stock $9K
Common Stock Shares Outstanding $82M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$248M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $3.8M
Capital Expenditures $3.9M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$503M
Cashflow From Financing $678M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$274M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $7M
Total Revenue $7M
Cost Of Revenue $3.8M
Costof Goods And Services Sold $3.8M
Operating Income -$327M
Selling General And Administrative $39M
Research And Development $295M
Operating Expenses $334M
Investment Income Net -
Net Interest Income $52M
Interest Income $52M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization -
Income Before Tax -$274M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$274M
Comprehensive Income Net Of Tax -
Ebit -$327M
Ebitda -$327M
Net Income -$274M

IDYA News

IDYA Profile

Ideaya Biosciences Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Ideaya Biosciences, Inc. (NASDAQ: IDYA) is a pioneering precision medicine oncology company headquartered in South San Francisco, California, dedicated to the discovery and development of targeted therapies that leverage molecular diagnostics to improve patient outcomes. The company’s innovative approach focuses on synthetic lethality, aiming to develop treatments that selectively target cancer cells with specific genetic profiles, addressing unmet needs in oncology. By integrating advanced biomarker analysis into its drug development process, Ideaya is well-positioned to enhance personalized treatment approaches for patients battling various malignancies.

VHAI
+66.66%
$0.00
CGBS
-39.47%
$0.03
BURU
-23.61%
$0.39
YYAI
-18.17%
$0.13
BITF
+8.44%
$5.84
NVDA
-2.55%
$183.50
TMQ
+47.54%
$9.67
PLUG
-0.25%
$3.89
NVTS
+30.49%
$13.00
CAN
+17.03%
$1.77
SSKN
+44.75%
$2.22
RGTI
+1.74%
$55.87
LAES
+19.88%
$7.34
DNN
+6.33%
$3.27
ITP
+24.30%
$0.32
BYND
-22.70%
$0.80
EDHL
+91.46%
$0.95
INTC
-2.12%
$36.42
AXDX
-61.36%
$0.03
CRML
+28.39%
$29.88
MNTS
+23.42%
$1.76
NAK
+2.81%
$2.73
IONZ
+6.95%
$2.46
SOUN
+10.25%
$19.14
DFLI
+44.03%
$1.57
F
+1.42%
$11.70
TLRY
-2.96%
$1.63
ONDS
+17.24%
$10.81
RR
+8.95%
$6.45
AMD
+2.99%
$222.90
DVLT
+15.00%
$1.95
WULF
+12.67%
$15.77
GPUS
-7.04%
$0.39
ETHD
+5.70%
$3.52
NUAI
+42.55%
$3.35
ERIC
+20.26%
$9.82
ACHR
+0.64%
$12.85
KDLY
-1.56%
$0.85
MARA
+9.33%
$22.12
UUUU
+11.50%
$26.50
RXRX
-0.99%
$5.47
CIFR
+3.93%
$21.14
QBTS
+5.48%
$42.84
UAMY
+9.24%
$18.25
JDZG
+37.23%
$2.58
BBD
+2.58%
$3.17
RMBL
+60.50%
$3.21
TSLA
-1.38%
$429.85
ADD
-25.47%
$0.05
AREC
+29.11%
$6.43
BTBT
+7.12%
$4.28
RIG
-1.87%
$3.14
CLSK
+9.75%
$21.99
USAR
+2.43%
$39.62
SRM
+53.27%
$10.30
PLTR
+2.50%
$181.65
ADAP
-11.93%
$0.15
SOFI
+2.18%
$27.73
NIO
-3.06%
$6.95
ABAT
+18.65%
$10.94
JOBY
+5.63%
$17.71
NOK
+4.57%
$5.49
IREN
+6.40%
$68.25
CLF
+0.72%
$13.93
WWR
+14.25%
$2.92
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
APLD
+9.34%
$37.44
AAL
+2.51%
$12.03
WLGS
-5.57%
$0.04
QS
-2.14%
$16.62
GGB
+2.85%
$3.24
MP
+2.98%
$97.90
ETWO
0.00%
$3.30
GWH
-19.99%
$7.24
ASST
-4.16%
$1.03
BMNR
-5.11%
$53.94
ASPI
+31.49%
$13.32
BTG
+0.74%
$5.34
AMC
-2.71%
$2.87
JBLU
+9.12%
$4.96
EOSE
+2.55%
$17.48
SNAP
-0.93%
$7.97
PFE
-0.14%
$24.69
QUBT
-0.04%
$21.45
AMZN
-0.61%
$218.72
AFMD
-34.94%
$0.18
NAKA
-6.15%
$0.80
GWAV
+84.53%
$15.70
GDXD
+0.44%
$0.73
NB
+4.41%
$11.81
BCRX
-10.95%
$6.26
RGTZ
-0.34%
$9.26
RF
+1.91%
$25.03
ABEV
+1.36%
$2.16
SLDP
+7.50%
$6.30
OPI
-16.97%
$0.20
ATXS
+38.78%
$11.75
WFC
+7.55%
$84.88
PYPL
-1.40%
$68.86
VHAI
+66.66%
$0.00
CGBS
-39.47%
$0.03
BURU
-23.61%
$0.39
YYAI
-18.17%
$0.13
BITF
+8.44%
$5.84
NVDA
-2.55%
$183.50
TMQ
+47.54%
$9.67
PLUG
-0.25%
$3.89
NVTS
+30.49%
$13.00
CAN
+17.03%
$1.77
SSKN
+44.75%
$2.22
RGTI
+1.74%
$55.87
LAES
+19.88%
$7.34
DNN
+6.33%
$3.27
ITP
+24.30%
$0.32
BYND
-22.70%
$0.80
EDHL
+91.46%
$0.95
INTC
-2.12%
$36.42
AXDX
-61.36%
$0.03
CRML
+28.39%
$29.88
MNTS
+23.42%
$1.76
NAK
+2.81%
$2.73
IONZ
+6.95%
$2.46
SOUN
+10.25%
$19.14
DFLI
+44.03%
$1.57
F
+1.42%
$11.70
TLRY
-2.96%
$1.63
ONDS
+17.24%
$10.81
RR
+8.95%
$6.45
AMD
+2.99%
$222.90
DVLT
+15.00%
$1.95
WULF
+12.67%
$15.77
GPUS
-7.04%
$0.39
ETHD
+5.70%
$3.52
NUAI
+42.55%
$3.35
ERIC
+20.26%
$9.82
ACHR
+0.64%
$12.85
KDLY
-1.56%
$0.85
MARA
+9.33%
$22.12
UUUU
+11.50%
$26.50
RXRX
-0.99%
$5.47
CIFR
+3.93%
$21.14
QBTS
+5.48%
$42.84
UAMY
+9.24%
$18.25
JDZG
+37.23%
$2.58
BBD
+2.58%
$3.17
RMBL
+60.50%
$3.21
TSLA
-1.38%
$429.85
ADD
-25.47%
$0.05
AREC
+29.11%
$6.43
BTBT
+7.12%
$4.28
RIG
-1.87%
$3.14
CLSK
+9.75%
$21.99
USAR
+2.43%
$39.62
SRM
+53.27%
$10.30
PLTR
+2.50%
$181.65
ADAP
-11.93%
$0.15
SOFI
+2.18%
$27.73
NIO
-3.06%
$6.95
ABAT
+18.65%
$10.94
JOBY
+5.63%
$17.71
NOK
+4.57%
$5.49
IREN
+6.40%
$68.25
CLF
+0.72%
$13.93
WWR
+14.25%
$2.92
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
APLD
+9.34%
$37.44
AAL
+2.51%
$12.03
WLGS
-5.57%
$0.04
QS
-2.14%
$16.62
GGB
+2.85%
$3.24
MP
+2.98%
$97.90
ETWO
0.00%
$3.30
GWH
-19.99%
$7.24
ASST
-4.16%
$1.03
BMNR
-5.11%
$53.94
ASPI
+31.49%
$13.32
BTG
+0.74%
$5.34
AMC
-2.71%
$2.87
JBLU
+9.12%
$4.96
EOSE
+2.55%
$17.48
SNAP
-0.93%
$7.97
PFE
-0.14%
$24.69
QUBT
-0.04%
$21.45
AMZN
-0.61%
$218.72
AFMD
-34.94%
$0.18
NAKA
-6.15%
$0.80
GWAV
+84.53%
$15.70
GDXD
+0.44%
$0.73
NB
+4.41%
$11.81
BCRX
-10.95%
$6.26
RGTZ
-0.34%
$9.26
RF
+1.91%
$25.03
ABEV
+1.36%
$2.16
SLDP
+7.50%
$6.30
OPI
-16.97%
$0.20
ATXS
+38.78%
$11.75
WFC
+7.55%
$84.88
PYPL
-1.40%
$68.86
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.